ArticleBreast cancer research : BCR2026

PREDICT v3.0 outperforms v2.2 in young (25-40 years) breast cancer patients according to real-world data from a large Swedish population-based registry.

Christine Lundgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.